Overview

Study of TV-1106 in Growth Hormone-Deficient Adults

Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the efficacy of 6 months of treatment with TV-1106 compared with placebo on body fat composition.
Phase:
Phase 3
Details
Lead Sponsor:
Teva Pharmaceutical Industries, Ltd.
Treatments:
Hormones